AGO-OVAR16 (VEG110655)

Trial Description: 
A Phase III Study to Evaluate the Efficacy and Safety of Pazopanib Monotherapy versus Placebo in Women who have not Progressed after First Line Chemotherapy for Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Lead Cooperative Group: 
Disease Site: 
Ovarian
Trial Status: 
Completed
Contact person: